Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

960
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
960
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

903
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
903
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

747
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
747
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

451
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
451
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

643
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
643

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Reported Experiences in Chronic Dermatological Conditions: Validation of the Romanian PSPSQ 2.0 Within Contemporary Dermatologic Care Pathways.

Diagnostics (Basel, Switzerland)·2026
Same author

Pressurized Intraperitoneal Aerosol Chemotherapy for Platinum-Resistant Ovarian Cancer: A Systematic Review and Meta-Analysis of Clinical Outcomes.

Journal of clinical medicine·2026
Same author

Chrononutrition Behaviors and BMI Change During the Transition to University Life in Young Adults: A Prospective Study.

Nutrients·2026
Same author

Intravenous Lidocaine as an Adjunct for Postoperative Recovery After Open Abdominal Surgery: A Systematic Review.

Journal of clinical medicine·2026
Same author

Guideline-Directed Medical Therapy Intensity, Ventricular Remodeling, and Clinical Outcomes After Acute Myocardial Infarction: A Single-Center Real-World Retrospective Cohort Study.

Biomedicines·2026
Same author

Impact of Smart Hearing Aid Technology on Self-Esteem in Patients with Sensorineural Hearing Loss: A Cross-Sectional Multivariate Study.

Healthcare (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jan 16, 2026

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
15:49

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System

Published on: October 16, 2013

32.5K

Colorectal Cancer-One Disease, Two Fires: Distinct Inflammatory Landscapes in Colon and Rectal Cancer.

Catalin Vladut Ionut Feier1,2, Florin Grama3,4, Georgiana Viorica Moise5,6

  • 1Abdominal Surgery and Phlebology Research Center, "Victor Babeș" University of Medicine and Pharmacy Timişoara, 300041 Timişoara, Romania.

Diagnostics (Basel, Switzerland)
|September 27, 2025
PubMed
Summary

Colon cancer exhibits a stronger systemic inflammatory response than rectal cancer, particularly in advanced stages. Inflammatory markers like SIRI, SII, and PLR may help stratify colorectal cancer patients beyond tumor location.

Keywords:
colon cancerelective surgeryemergency surgeryinflammatory biomarkersneutrophil-to-lymphocyte ratioplatelet-to-lymphocyte ratiorectal cancersystemic immune-inflammation indexsystemic inflammation

More Related Videos

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

11.5K
Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
06:05

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

9.8K

Related Experiment Videos

Last Updated: Jan 16, 2026

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
15:49

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System

Published on: October 16, 2013

32.5K
Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

11.5K
Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
06:05

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

9.8K

Area of Science:

  • Oncology
  • Immunology
  • Biomarkers

Background:

  • Systemic inflammatory indices are emerging prognostic tools in colorectal cancer (CRC).
  • Direct comparisons of these indices between colon cancer (CC) and rectal cancer (RC) are limited.
  • Understanding these differences is crucial for tailored treatment strategies.

Purpose of the Study:

  • To compare systemic inflammatory indices between CC and RC patients.
  • To investigate the association of these indices with clinicopathological factors.
  • To evaluate the potential of inflammatory markers for patient stratification in CRC.

Main Methods:

  • Retrospective matched-cohort study of 296 patients (148 CC, 148 RC) matched by stage, sex, and age.
  • Calculation of preoperative inflammatory markers: NLR, PLR, MLR, SIRI, SII, AISI.
  • Subgroup analyses based on Charlson Comorbidity Index, surgical context, and tumor stage.

Main Results:

  • CC patients showed significantly higher NLR, PLR, SIRI, SII, and AISI compared to RC patients.
  • Elevated inflammatory markers in CC were consistent across subgroups, including advanced tumors and higher comorbidity.
  • Specific markers like PLR, SIRI, and SII demonstrated significant differences in elective surgery and advanced tumor subgroups.

Conclusions:

  • Colon cancer is associated with a more pronounced systemic inflammatory response than rectal cancer.
  • Inflammatory indices (SIRI, SII, PLR) may offer valuable prognostic information irrespective of tumor location.
  • These markers could aid in stratifying colorectal cancer patients for personalized treatment approaches.